Literature DB >> 29519560

Mortality from infectious diseases in diabetes.

G Zoppini1, U Fedeli2, E Schievano2, M Dauriz3, G Targher3, E Bonora3, M C Corti2.   

Abstract

BACKGROUND AND AIMS: To investigate the risk of mortality from infections by comparing the underlying causes of death versus the multiple causes of death in known diabetic subjects living in the Veneto region of Northern Italy. METHODS AND
RESULTS: A total of 185,341 subjects with diabetes aged 30-89 years were identified in the year 2010, and causes of death were assessed from 2010 to 2015. Standardized Mortality Ratios (SMRs) with 95% confidence intervals (CIs) were computed with regional mortality rates as reference. The underlying causes of death and all the diseases reported in the death certificates were scrutinized. At the end of the follow-up, 36,382 subjects had deceased. We observed an increased risk of death from infection-related causes in subjects with diabetes with a SMR of 1.83 (95% CI, 1.71-1.94). The SMR for death from septicemia was 1.91 (95% CI, 1.76-2.06) and from pneumonia was 1.47 (95% CI, 1.36-1.59). The use of the multiple causes of death approach emphasized the association of infectious diseases with mortality.
CONCLUSION: The results of the present study demonstrate an excess mortality due to infection-related diseases in patients with diabetes; more interestingly, by routine mortality analyses, the results show a possible underestimation of the effect of these diseases on mortality.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Epidemiology; Health survey; Infections; Mortality; Sepsis

Mesh:

Year:  2018        PMID: 29519560     DOI: 10.1016/j.numecd.2017.12.007

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  13 in total

1.  Advanced glycation end-products reduce lipopolysaccharide uptake by macrophages.

Authors:  Atsuhiro Kitaura; Takashi Nishinaka; Shinichi Hamasaki; Omer Faruk Hatipoglu; Hidenori Wake; Masahiro Nishibori; Shuji Mori; Shinichi Nakao; Hideo Takahashi
Journal:  PLoS One       Date:  2021-01-25       Impact factor: 3.240

Review 2.  The patient-centered diabetes management during the COVID-19 pandemic.

Authors:  Noriko Kodani; Mitsuru Ohsugi
Journal:  Glob Health Med       Date:  2022-08-31

3.  Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory.

Authors:  Enzo Bonora; Salvatore Cataudella; Giulio Marchesini; Roberto Miccoli; Olga Vaccaro; Gian Paolo Fadini; Nello Martini; Elisa Rossi
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

4.  Importance of Awareness and Treatment for Diabetes in Influenza Vaccination Coverage of Diabetic Patients under 65 Years: A Population-Based Study.

Authors:  Yu Mi Ko; Seung Hyun Ko; Kyoungdo Han; Yong-Moon Park; Joon Young Choi; Shin Young Kim; So Hyang Song; Chi Hong Kim; Sung Kyoung Kim
Journal:  Diabetes Metab J       Date:  2020-05-29       Impact factor: 5.376

Review 5.  Diabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomes.

Authors:  Ahmed H Abdelhafiz; Demelza Emmerton; Alan J Sinclair
Journal:  Int J Clin Pract       Date:  2021-03-14       Impact factor: 3.149

Review 6.  Type 2 diabetes mellitus and sepsis: state of the art, certainties and missing evidence.

Authors:  Elisa Costantini; Massimiliano Carlin; Massimo Porta; Maria Felice Brizzi
Journal:  Acta Diabetol       Date:  2021-05-10       Impact factor: 4.280

7.  Antidiabetic, antioxidant, and anti-obesity effects of phenylthio-ethyl benzoate derivatives, and molecular docking study regarding α-amylase enzyme.

Authors:  Nidal Jaradat; Ahmad Khasati; Maram Hawi; Mohammed Hawash; Suhaib Shekfeh; Mohammad Qneibi; Ahmad M Eid; Mohammad Arar; Mohammed T Qaoud
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

8.  SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people.

Authors:  Enzo Bonora; Ugo Fedeli; Elena Schievano; Maddalena Trombetta; Mario Saia; Giovanna Scroccaro; Evelina Tacconelli; Giacomo Zoppini
Journal:  Nutr Metab Cardiovasc Dis       Date:  2021-06-29       Impact factor: 4.222

9.  Prevalence and impact of diabetes among people infected with SARS-CoV-2.

Authors:  G P Fadini; M L Morieri; E Longato; A Avogaro
Journal:  J Endocrinol Invest       Date:  2020-03-28       Impact factor: 4.256

10.  Increased Mortality Risk in People with Type 2 Diabetes Mellitus in Lithuania.

Authors:  Donata Linkeviciute-Ulinskiene; Auguste Kaceniene; Audrius Dulskas; Ausvydas Patasius; Lina Zabuliene; Giedre Smailyte
Journal:  Int J Environ Res Public Health       Date:  2020-09-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.